Clinical Trials
Study Title:
A Randomized, Double blind, Placebo Controlled, Active Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects with Relapsed or Refractory Diffuse Large B cell Lymphoma (DLBCL)
|
For more information about the trial above please contact the study team:
|